He led the landmark STEP clinical trials for Novo Nordisk that brought semaglutide to market, co-authored the influential Lancet Commission framework distinguishing clinical from preclinical obesity, and has written multiple books on the subject including a phenotype-based guide for clinicians and the popular Six Factors to Fit
Understanding why this happens requires looking at both the pharmacology of the drug and the individual factors that influence how the body responds to it
Timing considerations with GLP-1 medications: GLP-1 receptor agonists are typically administered once weekly (semaglutide [Ozempic, Wegovy], dulaglutide [Trulicity]) or once daily (liraglutide [Victoza, Saxenda]), with specific timing recommendations
it's the only professionally responsible choice
Glucagon-like Peptide-1 Receptor Agonists and Ocular Disease: Mechanisms, Evidence and Therapeutic Perspectives
Table 1 summarizes the dose adjustment of human doses